Marinomed Biotech AG (93Z) Income Statement
Marinomed Biotech AG Income Statement
Last quarter (Q2 2024), Marinomed Biotech AG's total revenue was $1.73M, a decrease of 9.59% from the same quarter last year. In Q2, Marinomed Biotech AG's net income was $-8.70M. See Marinomed Biotech AG’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 24 | Mar 23 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| $ 9.18M | $ 11.28M | $ 11.63M | $ 8.12M | $ 6.14M | |
| $ 1.14M | $ 2.14M | $ 1.42M | $ -641.70K | $ -512.30K | |
| $ 6.27M | $ 7.05M | $ 5.57M | $ 5.17M | $ 5.78M | |
| Depreciation and Amortization | $ 678.20K | $ 669.70K | $ 608.90K | $ 428.40K | $ 327.20K |
| $ -3.62M | $ -3.21M | $ -3.58M | $ -4.86M | $ -6.22M | |
| $ -5.13M | $ -5.75M | $ -4.14M | $ -6.96M | $ -6.21M | |
| $ -1.66M | $ -639.60K | $ -1.55M | $ 954.10K | $ -1.00M | |
| $ -6.79M | $ -6.39M | $ -5.69M | $ -6.01M | $ -7.21M | |
| $ -6.79M | $ -6.40M | $ -5.89M | $ -6.01M | $ -7.22M | |
| Per Share Metrics | |||||
| Basic EPS | $ -4.48 | $ -4.27 | $ -3.99 | $ -4.09 | $ -5.09 |
| Diluted EPS | $ -4.50 | $ -4.27 | $ -3.99 | $ -4.09 | $ -5.09 |
| Weighted Average Shares Outstanding | 1.52M | 1.50M | 1.48M | 1.47M | 1.42M |
| Weighted Average Shares Outstanding (Diluted) | 1.52M | 1.50M | 1.48M | 1.47M | 1.42M |
Currency in EUR
